top of page
Bianalisi
Investment Details
Bianalisi is the leading independent platform of integrated healthcare diagnostics in Italy, offering a full range of healthcare services in laboratory diagnostics, outpatient care and imaging diagnostics.
Current
Status
Italy
Country
Healthcare
Sector
Bianalisi
About
Headquartered north of Milan, Bianalisi is a leading Italian consolidation platform for clinical laboratory and specialist outpatient diagnostic services. The company has a significant presence in nine Italian regions (75% of population) and is actively expanding across other regions to complete its national coverage.
Working closely with the founder, co-investors and the management team, Columna’s investment strategy is to create a market leader in the fragmented Italian market for clinical diagnostic services through buy & build and the provision of outsourcing services to less efficient public and private healthcare structures.
Bianalisi is a company that has so far recorded the fastest growth in the Italian private healthcare market," says the new CEO, Giovanni Gianolli. "I will bring my experience and skills to achieve the challenging goals that await us in the short to medium term. I can count on the support of a renewed organization, which will see the Scientific Committee and a solid team of managers working in synergy, alongside all the staff and professionals committed every day in our facilities, serving patients, businesses, and the community.
Giovanni Gianolli, CEO
more investments
01
02
03
04
05
06
07
08
bottom of page